异动解读 | 科迪亚克科学股价盘中大涨5.08%,巴克莱上调目标价

异动解读
Aug 16, 2025

科迪亚克科学(Kodiak Sciences Inc.,股票代码:KOD)周五盘中股价大涨5.08%,引起投资者广泛关注。

推动股价上涨的主要原因是华尔街知名投行巴克莱上调了对该公司的目标价。巴克莱分析师将科迪亚克科学的目标价从4美元大幅上调至7美元,这一积极的评级调整显著提振了投资者信心。

科迪亚克科学是一家生物制药公司,专注于开发用于治疗视网膜疾病的新型疗法。尽管公司目前尚未有产品获得上市批准,但投资者对其研发管线中的潜在突破性药物抱有期待。巴克莱此次上调目标价可能反映了分析师对公司研发进展的乐观态度。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10